The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2018Charting a Path to Success for Clinical Trials in Patients with Inherited, GBA-linked Parkinson's Disease: PPMI Supplement
Promising Outcomes of Original Grant:
The original study is ongoing.Objectives for Supplemental Investigation:
We aim to determine whether fatty molecules called sphingolipids can serve as biomarkers —… -
Rapid Response Innovation Awards, 2014Optogenetics-based, Photo-switchable Model of Parkinson’s Disease for Drug Screening
Objective/Rationale:
Neurodegeneration has proven notoriously difficult to study. The main barrier to progress has been the challenging, heterogeneous nature of brain tissue. Optogenetics is a… -
Access to Data and Biospecimens, 2014Defining Non-motor Phenotypes in Parkinson’s Disease and Novel Strategies for Diagnosis
Objective/Rationale:
Although Parkinson’s disease (PD) is diagnosed as a movement disorder, motor deficits are preceded by non-motor features including cognitive, cardiovascular, gastrointestinal… -
Community Fast Track, 2003Regulation of Dopaminergic Pathways by Eph Family Receptors
Replacing dopaminergic neurons is an attractive alternative in the treatment of Parkinson’s disease (PD). However, a successful treatment relies not only on the introduction of new neurons, but also…
-
Biomarkers Across Neurodegenerative Diseases, 2014Cortical and Functional Distinctions in Alzheimer’s and Parkinson’s Diseases
Study Rationale:
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are clinically distinct disorders, but their pathologies overlap considerably. Understanding how these overlaps relate to the two… -
Alpha-synuclein Pathology, 2014Contrasting Pathological Versus Normal Alpha-synuclein Assemblies
Study Rationale:
Parkinson’s disease (PD) is characterized by Lewy bodies composed of the protein alpha-synuclein in dopamine-producing nerve cells. The protein aggregates are also…
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.